JP2009541759A - 分析物測定用生物流体加工方法および装置 - Google Patents
分析物測定用生物流体加工方法および装置 Download PDFInfo
- Publication number
- JP2009541759A JP2009541759A JP2009517023A JP2009517023A JP2009541759A JP 2009541759 A JP2009541759 A JP 2009541759A JP 2009517023 A JP2009517023 A JP 2009517023A JP 2009517023 A JP2009517023 A JP 2009517023A JP 2009541759 A JP2009541759 A JP 2009541759A
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- processed
- biological
- heating
- precipitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 21
- 238000005259 measurement Methods 0.000 title claims description 4
- 238000003672 processing method Methods 0.000 title abstract description 3
- 238000010438 heat treatment Methods 0.000 claims abstract description 74
- 238000000034 method Methods 0.000 claims abstract description 53
- 239000013060 biological fluid Substances 0.000 claims abstract description 35
- 230000001413 cellular effect Effects 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 6
- 239000012530 fluid Substances 0.000 claims description 100
- 210000004369 blood Anatomy 0.000 claims description 46
- 239000008280 blood Substances 0.000 claims description 46
- 238000012545 processing Methods 0.000 claims description 33
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- 238000004140 cleaning Methods 0.000 claims description 22
- 238000001556 precipitation Methods 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 230000009089 cytolysis Effects 0.000 claims description 10
- 238000001879 gelation Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000002776 aggregation Effects 0.000 claims description 8
- 230000015556 catabolic process Effects 0.000 claims description 8
- 238000005119 centrifugation Methods 0.000 claims description 8
- 238000006731 degradation reaction Methods 0.000 claims description 8
- 230000036425 denaturation Effects 0.000 claims description 8
- 238000004925 denaturation Methods 0.000 claims description 8
- 238000010606 normalization Methods 0.000 claims description 8
- 238000004220 aggregation Methods 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000003018 immunosuppressive agent Substances 0.000 claims description 7
- 239000012620 biological material Substances 0.000 claims description 6
- 229960003444 immunosuppressant agent Drugs 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 238000004611 spectroscopical analysis Methods 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 4
- 230000001861 immunosuppressant effect Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 238000005481 NMR spectroscopy Methods 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims description 2
- 108010036949 Cyclosporine Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 claims description 2
- 210000001124 body fluid Anatomy 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 229960001265 ciclosporin Drugs 0.000 claims description 2
- 229930182912 cyclosporin Natural products 0.000 claims description 2
- 239000003599 detergent Substances 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 238000011156 evaluation Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims description 2
- 230000008105 immune reaction Effects 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 2
- 229960002930 sirolimus Drugs 0.000 claims description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 2
- 229960001967 tacrolimus Drugs 0.000 claims description 2
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000002144 chemical decomposition reaction Methods 0.000 claims 2
- 238000005054 agglomeration Methods 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 239000012930 cell culture fluid Substances 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 238000003754 machining Methods 0.000 claims 1
- 239000012472 biological sample Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 36
- 210000003743 erythrocyte Anatomy 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 9
- 239000000203 mixture Substances 0.000 description 6
- 210000000601 blood cell Anatomy 0.000 description 5
- 239000011521 glass Substances 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229940124589 immunosuppressive drug Drugs 0.000 description 1
- 208000016245 inborn errors of metabolism Diseases 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NRVFDGZJTPCULU-UHFFFAOYSA-N meda Chemical compound Cl.CN(C)CCS NRVFDGZJTPCULU-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- -1 primary amine compound Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/44—Sample treatment involving radiation, e.g. heat
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9493—Immunosupressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06013762A EP1876450B1 (en) | 2006-07-03 | 2006-07-03 | A method for processing whole blood for analyte determination |
| EP06015470 | 2006-07-25 | ||
| PCT/EP2007/005849 WO2008003451A1 (en) | 2006-07-03 | 2007-07-02 | A method and device for processing a biological fluid for analyte determination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009541759A true JP2009541759A (ja) | 2009-11-26 |
| JP2009541759A5 JP2009541759A5 (https=) | 2010-08-26 |
Family
ID=38436819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009517023A Ceased JP2009541759A (ja) | 2006-07-03 | 2007-07-02 | 分析物測定用生物流体加工方法および装置 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7799579B2 (https=) |
| EP (2) | EP2249164B1 (https=) |
| JP (1) | JP2009541759A (https=) |
| CA (1) | CA2656133A1 (https=) |
| DK (1) | DK2249164T3 (https=) |
| ES (1) | ES2392494T3 (https=) |
| PL (1) | PL2249164T3 (https=) |
| WO (1) | WO2008003451A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013174610A (ja) * | 2008-07-25 | 2013-09-05 | Thermo Finnigan Llc | 体液検査における細胞性成分の崩壊 |
| JP2019537000A (ja) * | 2016-10-11 | 2019-12-19 | ハエモキネシス・ピーティーワイ．・リミテッド | レーザを使用した試料、標本、及び試薬のインキュベーションを増進するための方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012054639A2 (en) | 2010-10-22 | 2012-04-26 | T2 Biosystems, Inc. | Nmr systems and methods for the rapid detection of analytes |
| US8409807B2 (en) | 2010-10-22 | 2013-04-02 | T2 Biosystems, Inc. | NMR systems and methods for the rapid detection of analytes |
| US9562271B2 (en) | 2012-04-20 | 2017-02-07 | T2 Biosystems, Inc. | Compositions and methods for detection of Candida species |
| US9702864B2 (en) * | 2014-12-19 | 2017-07-11 | Thermo Finnigan Llc | Means for generating cell-disintegrated blood |
| WO2017127731A1 (en) | 2016-01-21 | 2017-07-27 | T2 Biosystems, Inc. | Nmr methods and systems for the rapid detection of bacteria |
| CN116818618A (zh) * | 2022-03-21 | 2023-09-29 | 深圳迈瑞生物医疗电子股份有限公司 | 血液样本分析仪及其控制方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09318627A (ja) * | 1996-05-27 | 1997-12-12 | Yamasa Shoyu Co Ltd | 腎不全またはバセドウ病における骨組織の代謝異常をスクリーニングする方法 |
| JP2001516880A (ja) * | 1997-09-18 | 2001-10-02 | アキューメトリックス・インコーポレイテッド | サンプルを受容し処理するための装置 |
| JP2003509822A (ja) * | 1999-09-16 | 2003-03-11 | モトローラ・インコーポレイテッド | 少量のサンプルのマイクロ波細胞溶解システムおよびその方法 |
| JP2004504604A (ja) * | 2000-07-14 | 2004-02-12 | ポール・フィルトレイション・アンド・セパレイションズ・グループ・インコーポレイテッド | ヘモグロビンセンサ |
| JP2005506541A (ja) * | 2001-10-26 | 2005-03-03 | エヌティーユー ベンチャーズ ピーティーイー リミテッド | 試料調製一体型チップ |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1498688A (en) * | 1975-07-16 | 1978-01-25 | Ici Ltd | Treatment of single cell protein |
| DE3107060A1 (de) * | 1981-02-25 | 1982-09-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Kontroll- oder eichserum und verfahren zu seiner herstellung |
| US4975246A (en) * | 1985-09-30 | 1990-12-04 | Charm Stanley E | High temperature, short time heating system and method of heating heat-sensitive material |
| US4839142A (en) * | 1985-09-30 | 1989-06-13 | Charm Stanley E | High temperature, short time heating system and method of sterilizing or pasteurizing heat sensitive biological fluids |
| US5334499A (en) * | 1989-04-17 | 1994-08-02 | Eastman Kodak Company | Methods of extracting, amplifying and detecting a nucleic acid from whole blood or PBMC fraction |
| US5512440A (en) | 1991-12-18 | 1996-04-30 | Becton Dickinson And Company | Process for lysing Mycobacteria |
| US6207201B1 (en) * | 1993-06-03 | 2001-03-27 | Amuchina International, Inc. | Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments |
| US5389335A (en) * | 1993-06-18 | 1995-02-14 | Charm Sciences, Inc. | High temperature, short time microwave heating system and method of heating heat-sensitive material |
| US6197553B1 (en) | 1994-07-15 | 2001-03-06 | Merck & Co., Inc. | Method for large scale plasmid purification |
| US5503064A (en) * | 1994-08-31 | 1996-04-02 | Custom Control Products, Inc. | Apparatus and method for controlling a pasteurizing system |
| US6114113A (en) | 1997-08-11 | 2000-09-05 | Chiron Corporation | High efficiency genetic modification method |
| AU9775398A (en) | 1997-09-23 | 1999-04-12 | Ib2, L.L.C. | Rapid thermal cycle processing methods and apparatus |
| US6033479A (en) * | 1998-04-22 | 2000-03-07 | Applied Materials, Inc. | Process gas delivery system for CVD having a cleaning subsystem |
| NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| WO2005058378A1 (en) * | 2003-12-12 | 2005-06-30 | Charm Sciences, Inc. | Method, device and system for thermal processing |
| US7592139B2 (en) * | 2004-09-24 | 2009-09-22 | Sandia National Laboratories | High temperature flow-through device for rapid solubilization and analysis |
-
2007
- 2007-07-02 WO PCT/EP2007/005849 patent/WO2008003451A1/en not_active Ceased
- 2007-07-02 EP EP10172912A patent/EP2249164B1/en not_active Not-in-force
- 2007-07-02 JP JP2009517023A patent/JP2009541759A/ja not_active Ceased
- 2007-07-02 DK DK10172912.7T patent/DK2249164T3/da active
- 2007-07-02 EP EP07765003A patent/EP2035836B1/en not_active Not-in-force
- 2007-07-02 CA CA002656133A patent/CA2656133A1/en not_active Abandoned
- 2007-07-02 ES ES10172912T patent/ES2392494T3/es active Active
- 2007-07-02 PL PL10172912T patent/PL2249164T3/pl unknown
- 2007-07-03 US US11/822,287 patent/US7799579B2/en not_active Expired - Fee Related
-
2010
- 2010-08-18 US US12/858,760 patent/US8231838B2/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09318627A (ja) * | 1996-05-27 | 1997-12-12 | Yamasa Shoyu Co Ltd | 腎不全またはバセドウ病における骨組織の代謝異常をスクリーニングする方法 |
| JP2001516880A (ja) * | 1997-09-18 | 2001-10-02 | アキューメトリックス・インコーポレイテッド | サンプルを受容し処理するための装置 |
| JP2003509822A (ja) * | 1999-09-16 | 2003-03-11 | モトローラ・インコーポレイテッド | 少量のサンプルのマイクロ波細胞溶解システムおよびその方法 |
| JP2004504604A (ja) * | 2000-07-14 | 2004-02-12 | ポール・フィルトレイション・アンド・セパレイションズ・グループ・インコーポレイテッド | ヘモグロビンセンサ |
| JP2005506541A (ja) * | 2001-10-26 | 2005-03-03 | エヌティーユー ベンチャーズ ピーティーイー リミテッド | 試料調製一体型チップ |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013174610A (ja) * | 2008-07-25 | 2013-09-05 | Thermo Finnigan Llc | 体液検査における細胞性成分の崩壊 |
| JP2019537000A (ja) * | 2016-10-11 | 2019-12-19 | ハエモキネシス・ピーティーワイ．・リミテッド | レーザを使用した試料、標本、及び試薬のインキュベーションを増進するための方法 |
| JP2023002576A (ja) * | 2016-10-11 | 2023-01-10 | ハエモキネシス・リミテッド | レーザを使用した試料、標本、及び試薬のインキュベーションを増進するための方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| PL2249164T3 (pl) | 2013-02-28 |
| EP2249164B1 (en) | 2012-09-19 |
| US7799579B2 (en) | 2010-09-21 |
| CA2656133A1 (en) | 2008-01-10 |
| US20080038834A1 (en) | 2008-02-14 |
| EP2035836A1 (en) | 2009-03-18 |
| US8231838B2 (en) | 2012-07-31 |
| WO2008003451A1 (en) | 2008-01-10 |
| EP2035836B1 (en) | 2013-02-27 |
| DK2249164T3 (da) | 2013-01-07 |
| EP2249164A1 (en) | 2010-11-10 |
| ES2392494T3 (es) | 2012-12-11 |
| US20100311153A1 (en) | 2010-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541759A (ja) | 分析物測定用生物流体加工方法および装置 | |
| JP6392830B2 (ja) | 生体関連物質測定装置 | |
| JP2022153471A (ja) | サンプル分析のための方法、機器、及びシステム | |
| CN102105796B (zh) | 体液中细胞成分的解离 | |
| JPH03181853A (ja) | 酵素免疫測定用カートリツジ、それを用いた測定方法及び測定装置 | |
| CN101535791A (zh) | 生物材料成分的测定 | |
| JP2011529173A5 (https=) | ||
| JP2009541759A5 (https=) | ||
| Burguera et al. | In vivo sample uptake and on-line measurements of cobalt in whole blood by microwave-assisted mineralization and flow injection electrothermal atomic absorption spectrometry | |
| EP1876450B1 (en) | A method for processing whole blood for analyte determination | |
| HK1147313A (en) | A method and device for processing a biological fluid for analyte determination | |
| JP2841839B2 (ja) | 生体液中の金属自動分析装置 | |
| Mota-Martorell et al. | Nonenzymatic Protein Damage in Cerebrospinal Fluid | |
| HUT72976A (en) | Process for determining the androstenone content of adipose tissues | |
| US20120107804A1 (en) | Disintegration of cellular components in body fluids | |
| TW202345974A (zh) | 生化分子合成及生物氣膠偵測系統及方法 | |
| CN119437828A (zh) | 用于制备用于蛋白质组分析的液体蛋白质样品的方法、装置和计算机软件 | |
| RU2376602C1 (ru) | Способ определения локализации белков в высохшей капле сыворотки (плазмы) крови | |
| JP2008256540A (ja) | カイロマイクロンの分析方法 | |
| JPH04177169A (ja) | 生体液中の金属自動分析装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100701 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100701 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20101227 Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20101228 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111020 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111027 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120126 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120509 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120809 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120816 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120904 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20130305 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130305 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130415 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20130515 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130716 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140114 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20140526 |